{BLR 2904} Agennix–Angioplasty–AntexBiologics- Anti-Infective Agents - Bearsden Bio–Bio–Transplant- Bladder Cancer-Brain Disorders–Canada-CDK2–CEA–Celtrix–Celtrix-Cognetix-Copernicus Therapeutics-Cortex Pharmaceuticals- CV Therapeutics-Endovasc-Gene Therapy Vectors–Genentech–GenVec–HIV–IGF–ImmunoGen–Immunomedics–Immunosuppressants–India–Integra–Intergen–Lactoferrin-Liposomes-Mabs–Matritech-Maxim Pharmaceuticals-Myriad Genetics-Nucleic Acids-Osiris-Ostex Intemational–Procept–Procyon-Prostate Can-cer-Protein Design Labs–STDs-Stem Cells–TAPS-Thrombolytic Drugs-tPA-Vaccines
- DOI
- 10.1089/blr.1999.18.266a
- Published
- 1999-06
- Container
- Biotechnology Law Report
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1089/blr.1999.18.266a,
title = {\{BLR 2904\} Agennix–Angioplasty–AntexBiologics- Anti-Infective Agents - Bearsden Bio–Bio–Transplant- Bladder Cancer-Brain Disorders–Canada-CDK2–CEA–Celtrix–Celtrix-Cognetix-Copernicus Therapeutics-Cortex Pharmaceuticals- CV Therapeutics-Endovasc-Gene Therapy Vectors–Genentech–GenVec–HIV–IGF–ImmunoGen–Immunomedics–Immunosuppressants–India–Integra–Intergen–Lactoferrin-Liposomes-Mabs–Matritech-Maxim Pharmaceuticals-Myriad Genetics-Nucleic Acids-Osiris-Ostex Intemational–Procept–Procyon-Prostate Can-cer-Protein Design Labs–STDs-Stem Cells–TAPS-Thrombolytic Drugs-tPA-Vaccines},
year = {1999},
journal = {Biotechnology Law Report},
doi = {10.1089/blr.1999.18.266a},
url = {https://doi.org/10.1089/blr.1999.18.266a}
}RIS
TY - JOUR
TI - {BLR 2904} Agennix–Angioplasty–AntexBiologics- Anti-Infective Agents - Bearsden Bio–Bio–Transplant- Bladder Cancer-Brain Disorders–Canada-CDK2–CEA–Celtrix–Celtrix-Cognetix-Copernicus Therapeutics-Cortex Pharmaceuticals- CV Therapeutics-Endovasc-Gene Therapy Vectors–Genentech–GenVec–HIV–IGF–ImmunoGen–Immunomedics–Immunosuppressants–India–Integra–Intergen–Lactoferrin-Liposomes-Mabs–Matritech-Maxim Pharmaceuticals-Myriad Genetics-Nucleic Acids-Osiris-Ostex Intemational–Procept–Procyon-Prostate Can-cer-Protein Design Labs–STDs-Stem Cells–TAPS-Thrombolytic Drugs-tPA-Vaccines
PY - 1999
JO - Biotechnology Law Report
DO - 10.1089/blr.1999.18.266a
UR - https://doi.org/10.1089/blr.1999.18.266a
ER - APA
{BLR 2904} Agennix–Angioplasty–AntexBiologics- Anti-Infective Agents - Bearsden Bio–Bio–Transplant- Bladder Cancer-Brain Disorders–Canada-CDK2–CEA–Celtrix–Celtrix-Cognetix-Copernicus Therapeutics-Cortex Pharmaceuticals- CV Therapeutics-Endovasc-Gene Therapy Vectors–Genentech–GenVec–HIV–IGF–ImmunoGen–Immunomedics–Immunosuppressants–India–Integra–Intergen–Lactoferrin-Liposomes-Mabs–Matritech-Maxim Pharmaceuticals-Myriad Genetics-Nucleic Acids-Osiris-Ostex Intemational–Procept–Procyon-Prostate Can-cer-Protein Design Labs–STDs-Stem Cells–TAPS-Thrombolytic Drugs-tPA-Vaccines. (1999). Biotechnology Law Report. https://doi.org/10.1089/blr.1999.18.266a
Source records
- crossref · retrieved 2026-09-25T17:03:32.345Z